The Japanese company Anges has announced that it has developed a vaccine against Covid-19 using an inactivated virus that can be manufactured quickly. It will quickly launch animal tests.
In the search for a solution against the coronavirus, the Japanese biopharmaceutical company Anges could well be one step ahead. She announced that she had found a vaccine against Covid-19 which, in addition, can be produced quickly. Animal tests will soon be launched.
The rising stock market
In France, all eyes are on chloroquine and Professor Raoult, director of the Institut hospitalo-universitaire (IHU) in Marseille, who is presenting promising results in the fight against the coronavirus pandemic. Larger scale trials have been launched to test this treatment, as well as others. At the Pasteur Institute in Paris, research is being carried out to find a vaccine against Covid-19 as quickly as possible.
Hope for a vaccine may come from Japan where, as reported i24 News, the biopharmaceutical company Anges announced on Tuesday March 24 that it has completed the development of a DNA vaccine against the new coronavirus. Animal tests will soon be launched. On March 5, the firm announced that it was embarking on the development of a vaccine against Covid-19, in association with the University of Osaka (Japan).
This DNA vaccine is produced using an inactivated virus and can be made quickly, raising hopes for a global solution. Following the announcement, the company’s shares jumped 17% at the opening of the Tokyo Stock Exchange, compared to 5.3% for the broader market, proof of the hope that this research arouses.
.
